Delivery Order SPE2DB20D3103-SPE2DB25FP8L8
Award Date 8/12/25
Potential Completion Date 8/13/25
Potential Value $41K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials totaling $16,217.68 with completion by September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ferumoxytol is an intravenous iron replacement therapy used in clinical settings, reflecting the pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials, with a ceiling value of $1,491.43 and an ultimate completion date of August 25, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials, with a contract value of $4,747.76 and an ultimate completion date of July 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 ml vials, a pharmaceutical product used primarily for iron replacement therapy. The contract, awarded on August 25, 2025, carries a ceiling value of $4,134.17 with an ultimate completion date of August 26, 2025. This delivery order utilizes firm fixed price pricing and was competitively awarded without set-aside restrictions. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,285.55 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This competitively awarded, firm fixed-price contract was executed on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ferumoxytol is an intravenous iron replacement therapy used to treat iron deficiency anemia, commonly utilized in...
- The Defense Logistics Agency awarded a delivery order valued at $11,624.29 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $22,345.60 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 ml vials. The contract, which was competitively awarded without set-aside designation, has a firm fixed price structure and an ultimate completion date of July 21, 2025. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,652.60 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This firm fixed-price, competitively awarded contract was executed on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,012.72 contract is for the supply of 510 mg/17 ml vials of the iron supplement Ferumoxytol, with a period of performance through April 2025. The award is not associated with a set-aside program and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
- The Defense Logistics Agency (DLA) awarded a $2,553.24 firm fixed price delivery order to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to supply the medication Ferumoxytol 510 mg/17 ml vial. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...